Provider of pharmaceutical and nutraceutical ingredients, Roquette, is excited to unveil its extensive range of excipients for moisture protection at CPHI Barcelona next week.
An expert from the company discusses how ever-changing patient needs and other dynamic factors are likely to impact pharma ingredient trends down the road.
An expert from the organization discusses ahead of his CPhI North America presentation how tomorrow’s drugs can’t all be formulated with yesterday’s excipients.
A leader from the organizer of the pharmaceutical event discusses what’s in store for the upcoming conference, and for the drug development industry itself.
A representative from IFF Pharma Solutions talks about significant challenges in drug development and improvements the industry can implement to overcome them.
Professionals from various corners of the life-sciences field share views on significant challenges of 2021, bright spots, and what to look for in 2022.
An expert from the specialty chemicals firm (and CPhI Worldwide speaker) explains trends and developments in excipients and how they drive advancements.
The excipients specialist shares findings from its research into the ins and outs of 3D powder bed printed tablets and how it can benefit drug development.
The pjarmaceutical excipient, intended for use in the formulation of flash orally dissolving tablets, is designed to disintegrate in less than 10 seconds.
A leader from the excipients firm discusses how ODTs appeal to seniors and patients on the go, and the formulation-related challenges with such tablets.
A representative from Clarivate explains how supply chain vulnerabilities can hurt stakeholders, including patients—and how one solution can close the gap.
A leader from the company says to ensure medicines keep reaching the patients that need them, the industry must revamp outdated technologies and techniques.
This month’s roundup of new excipients, manufacturing sites, partnerships, and other items includes news from DFE Pharma, Vetter, and other notable firms.
The pharma ingredients provider discusses new products, supply-chain obstacles, and what the future of the industry might hold, ahead of the online event.
The bipartisan bill calls for an assessment of the country’s pharma supply chain, including potential vulnerabilities and impact of foreign manufacturing.
Bolstered by manufacturing advancements, the global revenues of the pharmaceutical excipients market are expected to grow at a CAGR of 5.8% in the coming years.
Roquette has purchased a majority stake in excipient manufacturer Crest Cellose, in an aim to increase its footprint in India’s generic pharmaceutical market.
With more than 90 excipient manufacturers in China dedicated to the pharma industry, the country expects its output of excipients to more than double to about $8.9bn (€7.1bn), according to a new report.
Experts have predicted emerging Indian and Chinese markets will outpace Western markets as the $2.3bn oral solid dosage form (OSDF) excipients global market grows at a sustainable rate.
The Chinese Food and Drug Administration (SFDA) has confirmed that drugmakers and suppliers will take on more responsibility for ensuring excipient quality under new provisions.
The EFCG has welcomed the addition of excipient GMP requirements to the draft amendments of the EU falsified medicines directive but warned that deeper analysis is needed to establish which products warrant further regulation.
The costs of introducing any formal good manufacturing practice
(GMP) requirements for potentially high-risk pharmaceutical
excipients in the European Union would far exceed the likely
benefits, concludes an impact assessment for...
The European Fine Chemicals Group (EFCG) has called for stricter
regulation of pharmaceutical excipients in a bid to prevent
substandard and potentially dangerous products ending up in
medicinal drugs.
New legislation on the good manufacturing practice (GMP) of
pharmaceutical excipients in Europe, which could complicate the
quality control of imports of excipients to the EU and make it
unattractive for some vendors to remain in...
Unlike with active pharmaceutical ingredients (APIs), there are no
clear governmental good manufacturing practice (GMP) guidelines for
excipients in the US, Europe or China. Now the International
Pharmaceutical Excipients Council...
Excipients, often overlooked by pharmaceutical companies with their
attention firmly focused on active pharmaceutical ingredients, are
benefiting from an increasing awareness of their potential to cut
the costs of drug development.
Scientists at Chr Hansen's US research operations have developed a
gum acacia-based film coating, suitable for use in pharmaceuticals,
that combines low cost, long shelf life and low shipping costs.
The European Commission has updated its guidelines on the labelling
of excipients used in medicinal products and the manufacturing of
investigational drugs.
